BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38780943)

  • 1. Effectiveness of a School- and Primary Care-Based HPV Vaccination Intervention: The PrevHPV Cluster Randomized Trial.
    Thilly N; Michel M; Simon M; Bocquier A; Gagneux-Brunon A; Gauchet A; Gilberg S; Le Duc-Banaszuk AS; Bruel S; Mueller JE; Giraudeau B; Chevreul K;
    JAMA Netw Open; 2024 May; 7(5):e2411938. PubMed ID: 38780943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a school-based and primary care-based multicomponent intervention on HPV vaccination coverage among French adolescents: a cluster randomised controlled trial protocol (the PrevHPV study).
    Bocquier A; Michel M; Giraudeau B; Bonnay S; Gagneux-Brunon A; Gauchet A; Gilberg S; Le Duc-Banaszuk AS; Mueller JE; Chevreul K; Thilly N;
    BMJ Open; 2022 Mar; 12(3):e057943. PubMed ID: 35332045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a Health Care Professional Communication Training Intervention on Adolescent Human Papillomavirus Vaccination: A Cluster Randomized Clinical Trial.
    Dempsey AF; Pyrznawoski J; Lockhart S; Barnard J; Campagna EJ; Garrett K; Fisher A; Dickinson LM; O'Leary ST
    JAMA Pediatr; 2018 May; 172(5):e180016. PubMed ID: 29507952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-development of a school-based and primary care-based multicomponent intervention to improve HPV vaccine coverage amongst French adolescents (the PrevHPV Study).
    Bocquier A; Bruel S; Michel M; Le Duc-Banaszuk AS; Bonnay S; Branchereau M; Chevreul K; Chyderiotis S; Gauchet A; Giraudeau B; Hagiu DP; Mueller JE; Gagneux-Brunon A; Thilly N;
    Health Expect; 2023 Oct; 26(5):1843-1853. PubMed ID: 37312280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a School-Based Educational Intervention About the Human Papillomavirus Vaccine on Psychosocial Outcomes Among Adolescents: Analysis of Secondary Outcomes of a Cluster Randomized Trial.
    Davies C; Marshall HS; Zimet G; McCaffery K; Brotherton JML; Kang M; Garland S; Kaldor J; McGeechan K; Skinner SR;
    JAMA Netw Open; 2021 Nov; 4(11):e2129057. PubMed ID: 34726749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Training Pediatric Clinicians in Human Papillomavirus Communication Strategies on Human Papillomavirus Vaccination Rates: A Cluster Randomized Clinical Trial.
    Szilagyi PG; Humiston SG; Stephens-Shields AJ; Localio R; Breck A; Kelly MK; Wright M; Grundmeier RW; Albertin C; Shone LP; Steffes J; Rand CM; Hannan C; Abney DE; McFarland G; Kominski GF; Seixas BV; Fiks AG
    JAMA Pediatr; 2021 Sep; 175(9):901-910. PubMed ID: 34028494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.
    Msyamboza KP; Mwagomba BM; Valle M; Chiumia H; Phiri T
    BMC Public Health; 2017 Jun; 17(1):599. PubMed ID: 28651574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How can we improve the acceptability of vaccination against Human Papillomavirus (HPV) in France? An original qualitative study with focus groups comprising parents and school staff, interviewed separately.
    Ailloud J; Branchereau M; Fall E; Juneau C; Partouche H; Bonnay S; Oudin-Doglioni D; Michel M; Gagneux-Brunon A; Bruel S; Thilly N; Gauchet A;
    Vaccine; 2023 Jul; 41(31):4594-4608. PubMed ID: 37344259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving vaccination uptake among adolescents.
    Abdullahi LH; Kagina BM; Ndze VN; Hussey GD; Wiysonge CS
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011895. PubMed ID: 31978259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of interventions to improve HPV vaccination acceptance and uptake in school-based programs: Findings of a pilot project in Quebec.
    Dionne M; Étienne D; Witteman HO; Sauvageau C; Dubé È
    Vaccine; 2024 Jul; 42(18):3768-3773. PubMed ID: 38714451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Human Papillomavirus Vaccination School-Entry Requirements and Vaccination Initiation.
    Ko JS; Goldbeck CS; Baughan EB; Klausner JD
    JAMA Pediatr; 2020 Sep; 174(9):861-867. PubMed ID: 32597928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. School-based intervention for the prevention of HPV among adolescents: a cluster randomised controlled study.
    Grandahl M; Rosenblad A; Stenhammar C; Tydén T; Westerling R; Larsson M; Oscarsson M; Andrae B; Dalianis T; Nevéus T
    BMJ Open; 2016 Jan; 6(1):e009875. PubMed ID: 26817639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annual immunisation coverage report 2021.
    Hull B; Hendry A; Dey A; Brotherton J; Macartney K; Beard F
    Commun Dis Intell (2018); 2023 Aug; 47():. PubMed ID: 37817316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. School-based human papillomavirus vaccination program for increasing vaccine uptake in an underserved area in Texas.
    Kaul S; Do TQN; Hsu E; Schmeler KM; Montealegre JR; Rodriguez AM
    Papillomavirus Res; 2019 Dec; 8():100189. PubMed ID: 31654772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV.edu study protocol: a cluster randomised controlled evaluation of education, decisional support and logistical strategies in school-based human papillomavirus (HPV) vaccination of adolescents.
    Skinner SR; Davies C; Cooper S; Stoney T; Marshall H; Jones J; Collins J; Hutton H; Parrella A; Zimet G; Regan DG; Whyte P; Brotherton JM; Richmond P; McCaffrey K; Garland SM; Leask J; Kang M; Braunack-Mayer A; Kaldor J; McGeechan K
    BMC Public Health; 2015 Sep; 15():896. PubMed ID: 26373926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination coverage rates and predictors of HPV vaccination among eligible and non-eligible female adolescents at the Brazilian HPV vaccination public program.
    Faisal-Cury A; Levy RB; Tourinho MF; Grangeiro A; Eluf-Neto J
    BMC Public Health; 2020 Apr; 20(1):458. PubMed ID: 32252705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex intervention to promote human papillomavirus (HPV) vaccine uptake in school settings: A cluster-randomized trial.
    Davies C; Marshall HS; Brotherton JML; McCaffery K; Kang M; Macartney K; Garland SM; Kaldor J; Zimet G; Skinner SR;
    Prev Med; 2023 Jul; 172():107542. PubMed ID: 37172767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can physicians and schools mitigate social inequalities in human papillomavirus vaccine awareness, uptake and vaccination intention among adolescents? A cross-sectional study, France, 2021 to 2022.
    Moffroid H; Doglioni DO; Chyderiotis S; Sicsic J; Barret AS; Raude J; Bruel S; Gauchet A; Michel M; Gagneux-Brunon A; Thilly N; Mueller JE;
    Euro Surveill; 2023 Nov; 28(46):. PubMed ID: 37971661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of decision support on missed opportunities for human papillomavirus vaccination.
    Mayne SL; duRivage NE; Feemster KA; Localio AR; Grundmeier RW; Fiks AG
    Am J Prev Med; 2014 Dec; 47(6):734-44. PubMed ID: 25455116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the impact of multilevel evidence-based implementation strategies to enhance provider recommendation on human papillomavirus vaccination rates among an empaneled primary care patient population: a study protocol for a stepped-wedge cluster randomized trial.
    Finney Rutten LJ; Radecki Breitkopf C; St Sauver JL; Croghan IT; Jacobson DJ; Wilson PM; Herrin J; Jacobson RM
    Implement Sci; 2018 Jul; 13(1):96. PubMed ID: 30001723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.